Physician

Aliya Usman Khan, MD

According to 2025 Medicare claims, Aliya Khan, MD (NPI: 1487638870) practices rheumatology in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is DAYTON ARTHRITIS AND ALLERGY CENTER LLC (NPI: 1912087511; TIN: 311811998) and primary practice location at 45409-1332.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 285 traditional Medicare patients, billed 175,572 HCPCS/CPT codes, and received $2,180,059 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,332 prescription claims across 332 beneficiaries totaling $732,861 in drug costs, led by Enbrel (Etanercept). 2022 DME data shows 11 claims. Open Payments data shows 15 records totaling $310. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $976,093 to $2,180,059. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $610,373 and ending at $732,861. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	228	57,500	$976,093
2016	272	64,523	$1,157,676
2017	285	73,450	$1,235,575
2018	302	66,890	$1,272,910
2019	325	65,414	$1,418,708
2020	311	71,546	$1,508,242
2021	311	103,745	$1,627,255
2022	329	130,427	$1,830,557
2023	309	148,303	$2,074,981
2024	285	175,572	$2,180,059

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	284	1,993	$610,373
2016	255	1,472	$351,546
2017	255	1,134	$330,192
2018	252	1,055	$404,683
2019	246	891	$344,477
2020	245	860	$163,454
2021	259	952	$305,546
2022	315	1,190	$564,214
2023	330	1,575	$879,055
2024	332	1,332	$732,861

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	88	$58,009
2017	N/R	70	$66,354
2018	N/R	73	$114,833
2019	N/R	48	$84,919
2020	N/R	66	$99,278
2021	N/R	54	$110,397
2022	N/R	11	$61,797
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	80	293	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	242	473	$88
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	66	398	$45
96415	Administration of chemotherapy into vein, each additional hour	48	372	$20
96372	Injection of drug or substance under skin or into muscle	66	191	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel	Etanercept	12	392	$111,787
Rinvoq	Upadacitinib	15	510	$106,318
Humira(Cf)	Adalimumab	12	336	$94,205
Enbrel Mini	Etanercept	13	364	$93,791
Humira(Cf) Pen	Adalimumab	12	392	$90,610

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$310	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aliya Usman Khan, MD?

Tedicare shows public-source Medicare data for Aliya Usman Khan, MD (NPI 1487638870), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aliya Usman Khan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aliya Usman Khan, MD?

Aliya Usman Khan, MD is linked to DAYTON ARTHRITIS AND ALLERGY CENTER LLC (billing NPI 1912087511) in the available physician profile data.

Does Aliya Usman Khan, MD have Open Payments data?

Aliya Usman Khan, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.